Long-acting technologies
32 articles
LAT CAB Calls on AbbVie, Licensed Generic Manufacturers of G/P, and the Medicines Patent Pool to Fulfill their Commitment to Make Generic HCV Treatment Widely Available
Four years after MPP and AbbVie came to agreement on a voluntary license authorizing MPP to sublicense G/P to generic manufacturers, generic G/P is not available anywhere. More
Scientists Create Long-Acting Injectable Drug Delivery System for TB
Researchers showed in vivo efficacy of a long-acting injectable formulation of the TB drug rifabutin. More
MPP and MedinCell Sign Licence Agreement for mdc-STM, an Investigational Long-Acting Injectable Formulation to Fight Malaria Transmission
The non-exclusive licence agreement will enable MPP to support the identification of suitable partners for the development and commercialisation of mdc-STM. More
The LAT CAB Responds to MedinCell and Medicines Patent Pool License on a New Long-Acting Malaria Formulation
Every minute a child in Sub-Saharan Africa dies from malaria; these are preventable deaths! More
Community Mobilization to Ensure Health Systems’ Readiness for Long-Acting Therapies - Webinar Recording Now Available Online
Webinar organized by Treatment Action Group, INPUD and AfroCAB. More
